Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Therapeutic application of melatonin in mild cognitive impairment.

Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI.

Am J Neurodegener Dis. 2012;1(3):280-91. Epub 2012 Nov 18.

2.

The use of chronobiotics in the resynchronization of the sleep/wake cycle. Therapeutical application in the early phases of Alzheimer's disease.

Cardinali DP, Furio AM, Brusco LI.

Recent Pat Endocr Metab Immune Drug Discov. 2011 May;5(2):80-90. Review.

PMID:
22074583
3.

Clinical aspects of melatonin intervention in Alzheimer's disease progression.

Cardinali DP, Furio AM, Brusco LI.

Curr Neuropharmacol. 2010 Sep;8(3):218-27. doi: 10.2174/157015910792246209.

4.

Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study.

Furio AM, Brusco LI, Cardinali DP.

J Pineal Res. 2007 Nov;43(4):404-9.

PMID:
17910609
5.

The use of chronobiotics in the resynchronization of the sleep-wake cycle.

Cardinali DP, Furio AM, Reyes MP, Brusco LI.

Cancer Causes Control. 2006 May;17(4):601-9. Review.

PMID:
16596316
6.

Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent.

Cardinali DP, Furio AM, Reyes MP.

Ann N Y Acad Sci. 2005 Dec;1057:327-36.

PMID:
16399904
7.

Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei.

Furio AM, Cutrera RA, Castillo Thea V, Pérez Lloret S, Riccio P, Caccuri RL, Brusco LL, Cardinali DP.

Cell Mol Neurobiol. 2002 Dec;22(5-6):699-709.

PMID:
12585689
8.

The use of melatonin in Alzheimer's disease.

Cardinali DP, Brusco LI, Liberczuk C, Furio AM.

Neuro Endocrinol Lett. 2002 Apr;23 Suppl 1:20-3. Review.

PMID:
12019347
9.

Melatonin in sleep disorders and jet-lag.

Cardinali DP, Brusco LI, Pérez Lloret S, Furio AM.

Neuro Endocrinol Lett. 2002 Apr;23 Suppl 1:9-13. Review.

PMID:
12019344

Supplemental Content

Loading ...
Support Center